Savchenko Z I, Iushchuk N D, Tsyb A F, Briskin B S, Vengerov Iu Ia, Vertkin A L
Klin Med (Mosk). 2000;78(3):50-3.
The data are reported on novel eubiotic biofor's effects on immune status of 213 patients with intestinal dysbacteriosis (39 surgical gastroenterological patients, 43 patients with diarrheal infections, 50 AIDS patients, 81 cancer patients exposed to radiation and chemotherapy). It was found that bioflor acts as an antidysbacteriosis drug and as an immunostimulator. It stimulates T-cell immunity, phagocytosis, B-cell immunity. Immunostimulating effect of bioflor depends on dysbacteriosis degree and is maximal at its first stages.
报告了新型共生生物制剂对213例肠道菌群失调患者(39例外科胃肠病患者、43例腹泻感染患者、50例艾滋病患者、81例接受放疗和化疗的癌症患者)免疫状态的影响数据。发现生物制剂起到抗菌群失调药物和免疫刺激剂的作用。它刺激T细胞免疫、吞噬作用、B细胞免疫。生物制剂的免疫刺激作用取决于菌群失调程度,在其最初阶段效果最大。